surpass cvot tirzepatide Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial AHA 25: SURPASS-CVOT:Tirzepatide vs Dulaglutide
Pay in 4 interest-free payments of $7.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 21 - Nov 26






/assets/images/provider/photos/2775905.jpeg)




















